Clinical results of polidocanol sclerotherapy in venous malformation treatment: Patient-perceived improvement and satisfaction. (February 2023)

• Record Type: Journal Article
• Authors: Çay, Ferdi; Altunbulak, Ahmet Y; Özbay, Yakup; Eldem, Gonca; Çil, Barbaros E; Vargel, İbrahim; Kutluk, Mustafa T; Yalçın, Bilgehan; Peynircioğlu, Bora
• Is Part Of: Phlebology. Volume 38:Number 1(2023)
• Page Start: 36
• Page End: 43
• Publication Date: 2023-02
• Subjects: foam sclerotherapy -- patient-reported outcomes -- patient satisfaction -- ultrasound-guided sclerotherapy -- venous malformation; Veins -- Diseases -- Periodicals; 616.14
• DOI: 10.1177/02683555221142531
• Languages: English
• ISSNs: 0268-3555

Abstract

Purpose: This study evaluated the results of polidocanol sclerotherapy in the treatment of venous malformations (VM) including patient satisfaction, perceived improvement, and predictors of satisfaction. Material and Method: Patients with VM that underwent polidocanol foam sclerotherapy between June 2013 and July 2021 in a single center were retrospectively evaluated. Patient demographics, VM, and treatment characteristics were analyzed. Patient-reported outcomes and satisfaction were analyzed with a questionnaire. Results: This study included 232 (136, 58.6%, female) patients. The mean age was 24.49 ± 12.45 years (range 3–72). The clinical response rate was 82.3%. The rate of satisfaction was 82.3%, and 116 (50%) patients were significantly satisfied. There were no major complications. Clinical response and VM margin were related to satisfaction ( p < 0.01, p = 0.012, respectively). Clinical response to pretreatment swelling was related to significant satisfaction ( p = 0.02). Conclusion: Polidocanol sclerotherapy was safe and effective in VM treatment with high satisfaction and low complication rates.